MoonLake Immunotherapeutics reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Zug, Switzerland
SEC filing record 1 source field available
Fiscal year end
31 December
MoonLake Immunotherapeutics has filed 315 SEC EDGAR filings since 28 Aug 2020

SEC filing history

Showing 1-4 of 4 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-91803

AMENDMENT NO. 3 TO SCHEDULE 13D

Filing date
08 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91803

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
05 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91803

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
30 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-91803

THE SCHEDULE 13D

Filing date
18 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .